0001209191-22-047651.txt : 20220825
0001209191-22-047651.hdr.sgml : 20220825
20220825193617
ACCESSION NUMBER: 0001209191-22-047651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220823
FILED AS OF DATE: 20220825
DATE AS OF CHANGE: 20220825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sloan Leslie
CENTRAL INDEX KEY: 0001719455
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 221199226
MAIL ADDRESS:
STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC.
STREET 2: 901 S.MOPAC EXPWY,BARTONOAKSPLAZONE,#250
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-23
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001719455
Sloan Leslie
805 LAS CIMAS PARKWAY
SUITE 100
AUSTIN
TX
78746
0
1
0
0
Chief Operating Officer
Employee Stock Option (right to buy)
0.68
2022-08-23
4
A
0
130000
0.00
A
2032-08-22
Common Stock
130000
130000
D
The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested.
/s/ James Kastenmayer, by power of attorney
2022-08-25